Ertapenem prophylaxis of surgical site infections in elective colorectal surgery in China: A multicentre, randomized, double-blind, active-controlled study

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 12, 2014, Pages 3379-3386

  Leng, Xi Sheng ^a   Zhao, Yong Jie ^b   Qiu, Hui Zhong ^c   Cao, Yong Kuan ^d   Zhu, Wei Hua ^a   Shen, Ju Fang ^e   Paschke, Amanda ^f   Dai, Wei Min ^g   Caldwell, Nicole ^f   Wang, Jue ^e  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b TIANJIN PEOPLE'S HOSPITAL   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^d CHENGDU MILITARY GENERAL HOSPITAL   (China)

^e MSD China ^*  (China)

^f MERCK RESEARCH LABORATORIES   (United States)

^g PAREXEL INTERNATIONAL   (United States)

Author keywords

Ceftriaxone; Metronidazole; lactams

Indexed keywords

CEFTRIAXONE; ERTAPENEM; METRONIDAZOLE; PLACEBO; ANTIINFECTIVE AGENT; BETA LACTAM;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHINA; COLORECTAL SURGERY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LAPAROTOMY; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MULTICENTER STUDY; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SURGICAL INFECTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ADOLESCENT; ADVERSE EFFECTS; CLINICAL TRIAL; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PROCEDURES; SURGICAL WOUND INFECTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BETA-LACTAMS; CEFTRIAXONE; CHINA; COLORECTAL SURGERY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LAPAROTOMY; MALE; METRONIDAZOLE; MIDDLE AGED; PLACEBOS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84932597913     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku302     Document Type: Article

References (21)

1. Mangram AJ, Horan TC, Pearson ML et al. Guideline for the prevention of surgical site infection. Am J Infect Control 1999; 27: 97-134.
2. Baum ML, Anish DS, Chalmers TC et al. A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls. N Engl J Med 1981; 305: 795-9.
3. Papp-Wallace KM, Endimiani A, Taracila MA et al. Carbapenems: past, present, and future. Antimicrob Agents Chemother 2011; 55: 4943-60.
4. Scher K. Studies on the duration of antibiotic administration for surgical prophylaxis. Am Surg 1997; 63: 59-62.
5. Mecchia P. Comparative study of ceftriaxone versus cefazolin plus clindamycin as antibiotic prophylaxis in elective colorectal surgery. J Chemother 2000; 12 Suppl 3: 5-9.
6. Woodfield JC, Van Rij AM, Pettigrew RA et al. A comparison of the prophylactic efficacy of ceftriaxone and cefotaxime in abdominal surgery. Am J Surg 2003; 185: 45-9.
7. Woods RK, Dellinger EP. Current guideline for antibiotic prophylaxis of surgical wounds. Am Fam Physician 1998; 57: 2731-40.
8. Song F, Glenny AM. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 1988; 85: 1232-41.
9. Zanella E, Rulli F. A multicenter randomized trial of prophylaxis with intravenous cefepime + metronidazole or ceftriaxone + metronidazole in colorectal surgery. The 230 Study Group. J Chemother 2000; 12: 63-71.
10. Itani KM, Wilson SE, Awad SS et al. Ertapenem versus cefotetan prophylaxis in elective colorectal surgery. N Engl J Med 2006; 355: 2640-51.
11. Eagye KJ, Nicolau DP. Selection of prophylactic antimicrobial agent may affect incidence of infection in small bowel and colorectal surgery. Surg Infect (Larchmt) 2011; 12: 451-7.
12. Wilson SE, Turpin RS, Kumar RN et al. Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery. Surg Infect (Larchmt) 2008; 9: 349-56.
13. Liao XJ, Zhang W, Meng RG et al. [Prophylactic use of antibiotics in selective colorectal operation: a randomized controlled trial.]. Chin J Surg 2008; 46: 122-4. [Article in Chinese]
14. Milsom JW, Smith DL, Corman ML et al. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Trovafloxacin Surgical Group. Am J Surg 1998; 176 (6A Suppl): 46S-52S.
15. Horan TC, Gaynes RP, Martone WJ et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol 1992; 13: 606-8.
16. Smith RL, Bohl JK, McElearney ST et al. Wound infection after elective colorectal resection. Ann Surg 2004; 239: 599-605.
17. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med 1985; 4: 213-26.
18. Lin GL, Qiu HZ, Xiao Y et al. [Safety and efficacy of prophylactic single antibiotics administration in selective open colorectal surgery.]. Zhonghua Wei Chang Wai Ke Za Zhi 2012; 15: 1040-3. [Article in Chinese]
19. Fujita S, Saito N, Yamada T et al. Randomized, multicenter trial of antibiotic prophylaxis in elective colorectal surgery: single dose vs 3 doses of a second-generation cephalosporin without metronidazole and oral antibiotics. Arch Surg 2007; 142: 657-61.
20. Miransky J, Ruo L, Nicoletta S et al. Impact of a surgeon-trained observer on accuracy of colorectal surgical site infection rates. Dis Colon Rectum 2001; 44: 1100-5.
21. Itani KM, Jensen EH, Finn TS et al. Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery. Surg Infect (Larchmt) 2008; 9: 131-7.